Parametric Portfolio Associates’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$784K	Buy	45,497 +20,364	+81%	+$278K	﹤0.01%	2891
2021 Q4	$365K	Buy	25,133 +5,360	+27%	+$81.2K	﹤0.01%	3203
2021 Q3	$356K	Buy	+19,773	New	+$317K	﹤0.01%	3233
2021 Q2	–	Sell	-84,276	Closed	-$2.12M	–	3559
2021 Q1	$2.12M	Buy	+84,276	New	+$1.65M	﹤0.01%	2741
2020 Q2	–	Sell	-18,418	Closed	-$19K	–	3909
2020 Q1	$19K	Sell	18,418 -112,147	-86%	-$153K	﹤0.01%	3895
2019 Q4	$247K	Buy	130,565 +105,349	+418%	+$175K	﹤0.01%	3659
2019 Q3	$27K	Sell	25,216 -65,651	-72%	-$93.1K	﹤0.01%	3921
2019 Q2	$199K	Buy	90,867 +33,646	+59%	+$183K	﹤0.01%	3740
2019 Q1	$343K	Sell	57,221 -39,201	-41%	-$260K	﹤0.01%	3500
2018 Q4	$713K	Sell	96,422 -7,604	-7%	-$78.4K	﹤0.01%	3154
2018 Q3	$1.51M	Sell	104,026 -7,339	-7%	-$126K	﹤0.01%	2888
2018 Q2	$2.22M	Buy	111,365 +66,254	+147%	+$1.22M	﹤0.01%	2615
2018 Q1	$790K	Buy	45,111 +20,077	+80%	+$425K	﹤0.01%	3129
2017 Q4	$617K	Buy	25,034 +2,218	+10%	+$54K	﹤0.01%	3235
2017 Q3	$589K	Sell	22,816 -5,427	-19%	-$145K	﹤0.01%	3325
2017 Q2	$766K	Sell	28,243 -27,154	-49%	-$738K	﹤0.01%	3129
2017 Q1	$1.65M	Buy	55,397 +22,223	+67%	+$641K	﹤0.01%	2572
2016 Q4	$900K	Buy	+33,174	New	+$846K	﹤0.01%	2898

Other funds holding ACRS